Cache Valley Virus Disease

The FDA accepted a supplemental biologics license application for FluMist, AstraZeneca’s nasal spray influenza vaccine, which could be the country’s first self-administered influenza vaccine.

A test developed to detect Cache Valley virus and other similar and uncommon viruses yielded fast and accurate results, which could make testing for these viruses easier in the future, according to a study.